We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000708:SZSECitic Pacific Special Steel Group Co., Ltd Analysis

Data as of 2026-06-07 - not real-time

CN¥13.57

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Citic Pacific Special Steel is trading at CNY 13.57, well below its 20‑day (CNY 14.41), 50‑day (CNY 15.50) and 200‑day (CNY 15.03) moving averages, indicating a technical oversold condition. The RSI of 29.8 reinforces this view, while the MACD remains bearish but only slightly below its signal line, suggesting limited downside momentum. The stock sits near its identified support at CNY 13.32 and faces resistance around CNY 15.86. Fundamentally, the company offers a solid 4.76% dividend yield with a payout ratio of 60%, strong free cash flow, and an ROE of 13.3%, but revenue has contracted by 1.3% and leverage is high (debt‑to‑equity ≈ 68%).
The DCF‑derived fair value of CNY 21.35 implies an upside of over 50% versus the current price, and analysts have issued a “strong buy” with a median target of CNY 20.7. Low beta (≈ 0.15) and a 30‑day volatility of 27% suggest modest market‑wide risk, while stable trading volumes support adequate liquidity. Overall, the stock appears fundamentally undervalued, dividend‑rich, and positioned for a potential rebound, though debt levels and cyclical steel exposure warrant caution.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near technical support and oversold RSI
  • Attractive dividend yield with sustainable payout
  • Low beta indicating limited market volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value suggests >50% upside
  • Analyst strong‑buy rating and median target of CNY 20.7
  • Strong free cash flow supporting dividend continuity

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term infrastructure demand for specialty steel in China
  • Consistent dividend income enhancing total return
  • Reasonable valuation multiples (PE ≈ 11.6, PB ≈ 1.5) despite high leverage

Key Metrics & Analysis

Financial Health

Revenue Growth-1.30%
Profit Margin5.66%
P/E Ratio11.6
ROE13.33%
ROA4.38%
Debt/Equity68.04
P/B Ratio1.5
Op. Cash FlowCN¥15.7B
Free Cash FlowCN¥9.9B

Technical Analysis

TrendNeutral
RSI29.8
SupportCN¥13.32
ResistanceCN¥15.86
MA 20CN¥14.41
MA 50CN¥15.50
MA 200CN¥15.03
MACDBearish
VolumeStable
Fear & Greed Index83.02

Valuation

Fair ValueCN¥21.35
Target PriceCN¥20.70
Upside/Downside52.54%
GradeUndervalued
TypeBlend
Dividend Yield4.76%

Risk Assessment

Beta0.15
Volatility27.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.